Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →25
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
6,993
Total Claims
$340K
Drug Cost
738
Beneficiaries
$461
Cost/Patient
Risk Score Breakdown 25/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+36%
Opioid rate vs peers
62.3% vs 45.9% avg
-5%
Cost per patient vs peers
$461 vs $483 avg
+16%
Brand preference vs peers
4.8% vs 4.1% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
62.3%
Opioid Rate
4,355
Opioid Claims
$294K
Opioid Cost
41.0%
Long-Acting Rate
This provider's opioid prescribing rate of 62.3% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 335 claims · $146K
Generic: 6,658 claims · $194K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 213 | $96K |
| Tramadol Hcl | 536 | $47K |
| Oxymorphone Hcl | 57 | $34K |
| Oxycodone Hcl/Acetaminophen | 782 | $18K |
| Fentanyl | 171 | $18K |
| Tapentadol Hcl | 11 | $17K |
| Oxycodone Hcl | 48 | $15K |
| Morphine Sulfate | 569 | $12K |
| Gabapentin | 852 | $11K |
| Hydrocodone/Acetaminophen | 1,359 | $11K |
| Hydrocodone Bitartrate | 27 | $8,733 |
| Buprenorphine | 31 | $7,854 |
| Diclofenac Sodium | 94 | $4,687 |
| Methocarbamol | 411 | $3,425 |
| Chlorzoxazone | 72 | $2,264 |
Prescribing Profile
37
Unique Drugs
25.0
Anomaly Score
Patient Profile
70
Avg Age
66%
Female
1.32
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data